findmyKOL
Clinical trialNCT04503733UnknownPhase 1Interventional

A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension

SponsorGmax Biopharm LLC.Enrollment48Pulmonary Arterial Hypertension
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Randomized, Placebo-Controlled, Double-blind, Dose Escalation Study to Assess Safety, Efficacy and Pharmacokinetics of GMA301 Injection in Subjects with Pulmonary Arterial Hypertension
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Peking Union Medical College Hospital - Dongcheng District

    Beijing, China

    Recruiting
  • Xiangya Hospital, Central South University

    Changsha, China

    Recruiting
  • the First Affiliated Hospital of Chongqing Medical University

    Chongqing, China

    Recruiting
  • Guangdong General Hospital

    Guangzhou, China

    Recruiting
  • Shanghai Pulmonary Hospital

    Shanghai, China

    Recruiting
  • the First Affiliated Hospital of Xi'An Jiaotong University

    Xi'an, China

    Recruiting
United States
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Q4W GMA301 IV injections
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Oct 2020
Primary completion
26 Oct 2022
Completion
10 Jun 2023
Last update posted
14 Jan 2022
Registered enrollment
48
Registry id
NCT04503733
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.